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 Abstract 
  Background and Purpose:   Our aim was to confirm the clinical relationship between the Kura-
shiki Prehospital Stroke Scale (KPSS) scored by paramedics and favorable outcomes in patients 
with modified Rankin scale (mRS) scores of 0–1 assessed 3 months after symptom onset.  Meth-
ods:   We enrolled patients with acute stroke and transient ischemic attack showing symptoms 
on admission. Paramedics transferred patients to our hospital after estimating stroke severity 
using the KPSS. After categorizing patients into either the mRS 0–1 group (favorable outcome) 
or the mRS 2–6 group (no favorable outcome), we compared the background data between the 
two groups. We assessed KPSS scores predictive of a favorable outcome. Multivariate regression 
modeling was conducted to identify factors independently associated with a favorable out-
come.   Results:   The study cohort comprised 147 patients with a premorbid status of mRS 0–1: 
69 patients (47%) of them were in the mRS 0–1 group and 78 (53%) in the mRS 2–6 group at the 
follow-up 3 months after symptom onset. The median KPSS score was lower in the mRS 0–1 
group than in the mRS 2–6 group (1 vs. 4, p   !  0.001). After classifying the 147 patients into KPSS 
tertiles with thresholds of 2 and 4, the frequency of mRS 0–1 gradually decreased with increas-
ing KPSS score (lower KPSS, 67.2%; middle KPSS, 47.6%, and higher KPSS, 21.3%; p  !  0.001). KPSS 
score   !  3 was able to predict a favorable outcome with 67% sensitivity and 71% specificity, and 
independently associated with mRS 0–1 (odds ratio, 3.0; 95% confidence interval, 1.2–7.3; p = 
0.015).   Conclusion:   KPSS score   !  3 apparently presents a reasonable cutoff for predicting a fa-
vorable outcome in patients with acute cerebral ischemia.    Copyright © 2011 S. Karger AG, Basel 
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 Introduction 
  Since the approval of intravenous tissue plasminogen activator (IV t-PA) for ischemic 
stroke treatment in the United States   [1]  , stroke care has become highly time dependent. To 
broaden the eligibility of patients for IV t-PA, transportation by ambulance supported by 
emergency medical services (EMS) is needed to minimize the duration from symptom onset 
to hospital arrival and decrease the time to physical examination on admission   [2]  . As half 
of the patients with signs or symptoms of acute stroke access initial medical care using an 
ambulance   [3]  , appropriate identification of acute stroke by EMS paramedics possibly in-
creases the number of patients who may benefit from IV t-PA.
    To immediately transport the patient to the closest and most appropriate facility, spe-
cifically for stroke bypass surgery, two types of prehospital stroke scales are required in the 
field: a scale for identifying stroke and a scale for assessing stroke severity. While novel stroke 
screening instruments for identifying possible stroke patients (e.g. the Los Angeles Prehos-
pital Stroke Screen and the Cincinnati Prehospital Stroke Screen) have already been used in 
onset scenes   [4, 5]  , prehospital stroke severity scales (PSSSs) have gained wide attention over 
the last decade. PSSSs representing basic modifications of the full 15-variable National In-
stitutes of Health Stroke Scale (NIHSS) include the Los Angeles Motor Scale (LAMS), a 
shortened version of the NIHSS (sNIHSS), a simple 3-item stroke scale (3-ISS), and the Kura-
shiki Prehospital Stroke Scale (KPSS;   table 1  )   [6–9]  . The KPSS comprises four items: level of 
consciousness; disturbance of consciousness; motor weakness, and language. Scores for the 
KPSS range from 0 to 13, with the maximum (13 points) representing the most severe symp-
toms  [6] . As paramedics are able to decide on appropriate transportation in accordance with 
stroke severity, estimating not only the possibility but also the severity of stroke will be more 
practical for prehospital stroke care   [10]  . Indeed, when stroke neurologists assessed stroke 
severity using PSSSs (e.g. LAMS, sNIHSS, and 3-ISS), these PSSSs were able to predict the 
presence of arterial occlusion   [9, 11]   and long-term outcome   [7, 8]  , as well as NIHSS. How-
ever, the question of whether these assessments using PSSSs have been realistically verified 
in the prehospital setting remains. Our aim was thus to clarify the relationship between the 
KPSS score recorded by paramedics and outcome 3 months after symptom onset.
  Subjects  and  Methods 
 The study cohort comprised consecutive patients with ischemic stroke or transient isch-
emic attack with symptoms on admission who were transferred to our facility within 24 h of 
onset between May 2007 and April 2010. The following clinical background data of all pa-
tients were collected: (1) age and gender; (2) past history; (3) duration from onset to admis-
sion; (4) NIHSS score evaluated by stroke neurologists on admission; (5) KPSS score evalu-
ated by paramedics prior to or during transportation; (6) presence of proximal arterial oc-
clusion and infarct size assessed by neuroimaging using computed tomography or magnetic 
resonance images immediately after admission; (7) use of IV t-PA; (8) premorbid status, and 
(9) outcome 3 months after onset.
  The four items in the KPSS (level of consciousness; disturbance of consciousness; motor 
weakness, and language) were chosen and modified based on the full NIHSS. In accordance 
with the prehospital stroke care recommendations of the Japanese Society for Emergency 
Medicine, immediately after paramedics arrived at the scene, the condition of the patient 
suspected of suffering a stroke was evaluated   [12]  . When ischemic stroke or transient isch-
emic attack was considered possible, neurological severity was assessed using the KPSS   [12]  . 
Before transferring the patients to our facility, the paramedics provided precise information 30
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to the staff in the emergency room. In most cases, stroke neurologists were already provided 
with information on the patient, including vital signs (blood pressure, heart rate, respiratory 
rate, and oxygen saturation), time of symptom onset, situation of the onset location, past pa-
tient history, and the KPSS score. The NIHSS score was determined by stroke neurologists 
on arrival of the patient at our hospital.
    To achieve a precise diagnosis, we performed diffusion-weighted magnetic resonance 
imaging and angiography, and carotid duplex ultrasonography immediately after admission, 
if no contraindications were present. A large infarct was diagnosed if more than one third of 
the territory of the middle cerebral artery (MCA) was affected on initial diffusion-weighted 
imaging   [13]  . Proximal arterial occlusion was defined as occlusion of the main trunk of the 
intra- and/or extracranial artery and the corresponding symptoms. Patients diagnosed with 
hyper-acute stroke received IV t-PA according to previously published criteria, if eligible  [13] . 
Outcome 3 months after onset was determined using the modified Rankin scale (mRS). A 
favorable outcome was defined as mRS 0 or 1. All study protocols were approved by the In-
stitutional Review Board of the Kawasaki Medical School (No. 587).
  A n a l y s i s  
  After identifying cases with premorbid status mRS 0–1, we classified patients into two 
groups according to the postmorbid status 3 months after onset: patients in the mRS 0–1 
group had a favorable outcome and those in the mRS 2–6 group had no favorable outcome. 
We then categorized all patients into KPSS tertiles, in order to estimate the proportion of 
Table 1.   Kurashiki Prehospital Stroke Scale
Scoring (total disorder: 13 points)
Level of consciousness
Check level of consciousness
Alert normal: 0 points
Arousal by stimulation 1 point
No response  2 points
Consciousness disturbance
Ask patient’s name
Correct normal: 0 points
Incorrect  1 point
Motor weakness (kinetic paralysis)
Ask the patient to close eyes, raise arms to the front with palms down (with gestures) right hand left hand
Able to keep arms raised in parallel  normal: 0 points normal: 0 points
Able to raise arms but not to keep them in position so that they go downward  1 point  1 point
Unable to raise arms  2 points  2 points
Instruct the patient to close eyes, raise legs from the bed to the front with gestures right leg left leg
Able to keep legs raised in parallel normal: 0 points normal: 0 points
Able to raise legs but not to keep them in position so that they go downward  1 point   1 point
Unable to raise legs  2 points  2 points
Language
Ask the patient to say ‘It’s fine today’ repeatedly
Able to clearly say it repeatedly  normal: 0 points
Either unclear (slurred) or abnormal  1 point
Silent, unable to understand linguistically  2 points
Total .... points31
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patients with mRS 0–1 in each tertile. The cutoff KPSS score for mRS 0–1 was then calcu-
lated by plotting sensitivity and specificity curves, and background data were compared be-
tween mRS 0–1 and mRS 2–6 groups. Significant trends were examined using the    2  test and 
the Mann-Whitney U test. Variables showing values of p   !   0.1 in univariate analyses and 
well-known variables related to stroke prognosis (age, atrial fibrillation, blood glucose level 
on admission, and baseline neuroimaging)   [14–16]   were considered as potential explanatory 
variables. Multivariate logistic regression analyses were then conducted to estimate factors 
independently associated with mRS 0–1. Correlations between KPSS and NIHSS scores were 
analyzed using Spearman’s rank correlation. Statistical analyses were performed using 
PASW statistics (version 18.0) software (SPSS, Chicago, Ill., USA). Values of p   !   0.05 were 
considered significant.
  R e s u l t s  
  A total of 238 consecutive patients with ischemic stroke or symptomatic transient isch-
emic attack on admission (median age, 75 years; 139 men, 99 women; median NIHSS score, 
6) were transferred to our hospital. Regarding the premorbid status, 147 of the 238 patients 
(61.8%) were mRS 0–1 prior to stroke onset. In these patients, an excellent correlation was 
evident between KPSS and NIHSS scores (R = 0.728, p   !   0.001).
    We classified these 147 patients into two groups (  table 2  ): the mRS 0–1 group (n = 69; 
median age, 70 years; 51 men, 18 women) and the mRS 2–6 group (n = 78; median age, 75 
years; 44 men, 34 women). The mRS 0–1 group was significantly younger than the mRS 2–6 
group (p = 0.007). Median NIHSS score was higher in the mRS 2–6 group than in the mRS 
0–1 group (11 vs. 2, respectively; p   !   0.001).
Table 2.   Clinical background data of ischemic stroke patients in mRS 0–1 and mRS 2–6 groups
mRS 0–1 group
(n = 69)
mRS 2–6 group
(n = 69)
p value
Median age (IQR), years 70 (60–76) 75 (66–83) 0.007
Males, n (%) 51 (73.9) 44 (56.4) 0.038
Past history, n (%)
Hypertension 43 (62.3) 54 (69.2) 0.389
Diabetes mellitus 17 (24.6) 18 (23.1) 0.848
Hyperlipidemia 17 (24.6) 22 (28.2) 0.709
Smoking 39 (56.6) 38 (48.7) 0.409
Atrial fibrillation 13 (18.8) 21 (26.9) 0.327
Ischemic stroke 7 (10.1) 11 (14.1) 0.615
Time from onset to admission ≤3 h, n (%) 43 (62.3) 40 (51.3) 0.187
Median NIHSS (IQR) 2 (1–4) 11 (5–18) <0.001
Median KPSS (IQR) 1 (0–3) 4 (2–9) <0.001
KPSS <3, n (%) 46 (66.7) 23 (29.5) <0.001
Infarct area of MCA >1/3 5/62 (8.1) 19/67 (28.4) 0.003
Proximal arterial occlusion, n (%) 17 (24.6) 45 (57.7) <0.001
Median blood glucose (IQR), mg/dl  130 (107–152) 137 (113–167) 0.261
IV t-PA, n/cases within 3 h of onset (%) 8/43 (18.6) 27/40 (67.5) <0.001
I  QR = Interquartile range.32
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    Regarding the KPSS score, after categorizing all 147 cases in KPSS tertiles using thresh-
olds scores of 2 and 4, we compared the proportion of patients with mRS 0–1 among KPSS 
tertiles. Patients with mRS 0–1 assessed 3 months after onset comprised 39 of 58 patients 
(67.2%) in the lower KPSS tertile (KPSS   !  2), 20 of 42 patients (47.6%) in the middle KPSS 
tertile, and 10 of 47 patients (21.3%) in the higher KPSS tertile (p   !   0.001). Patients with low-
er KPSS achieved more favorable outcomes than those with higher KPSS.
    Comparing background data between mRS 0–1 and 2–6 groups again, the KPSS score 
was significantly lower in the mRS 0–1 group (median KPSS; 1 vs. 4, p   !   0.001,   table 2 ).  The 
cutoff KPSS score for predicting mRS 0–1 at 3 months after onset was 3, with a sensitivity of 
67% and a specificity of 71% (  fig. 1  ). Patients with KPSS   !  3 were more frequently in the mRS 
0–1 group than in the mRS 2–6 group (66.7 vs. 29.5%, p   !   0.001;   table 2  ). Concerning the in-
farct area in patients showing ischemic lesions in the territory of the MCA, patients with a 
large infarct were more often in the mRS 2–6 group (28.4%) than in the mRS 0–1 group (8.1%, 
p = 0.003). IV rt-PA was administered to 8 of 43 patients (18.6%) with hyper-acute ischemic 
stroke in the mRS 0–1 group and 27 of 40 patients (67.5%) in the mRS 2–6 group (p   !   0.001).
    Factors associated with mRS 0–1 were analyzed using multivariate logistic regression 
analysis. NIHSS score was considered a confounding factor and excluded from analysis. The 
only factor independently associated with mRS 0–1 was KPSS   !  3 (odds ratio, 3.0; 95% con-
fidence interval, 1.2–7.3, p = 0.015;   fig. 2  ). 
  Discussion 
 The present results confirmed good validity for the initial KPSS score in predicting clin-
ical outcome 3 months after symptom onset, which was assessed using the mRS to quantify 
functional activities and global handicap of daily living. These findings are supportive of the 
  Fig. 1.   Cutoff KPSS score for mRS 0–1 plotted on a sensitivity-specificity curve. 33
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previous finding that the LAMS correlates with functional outcome at 3 months as well as 
the full NIHSS   [7]  . The reason for this relationship may be as follows. First, clinical progno-
sis of stroke patients was strongly associated with initial stroke severity, which is generally 
assessed using the NIHSS  [17] . Indeed, because an excellent correlation was evident between 
KPSS and NIHSS scores in our series, KPSS score   !  3 should be considered as a factor inde-
pendently associated with a favorable outcome 3 months after onset.
    Our assessment of stroke severity was performed in a straightforward manner by para-
medics in the prehospital field. Actually, the KPSS, LAMS, sNIHSS, and 3-ISS are simple 
scoring systems   [7–9]  , but results from previous investigations might have been influenced 
by the setting (field in the present study vs. emergency room in the other three studies) or 
examiner (paramedics in this study vs. physicians in other studies). We thus consider that 
this examination using the KPSS in a realistic situation should be sufficiently robust to con-
firm the potential for PSSSs.
    What is the essential information for assessing possible stroke patients as having mild 
or severe symptoms in prehospital scenarios? Two applications should be outlined in this 
regard. First, when neurological symptoms deteriorate during transportation, an urgent and 
precise diagnosis in a stroke center is required to assess and rescue vulnerable brain tissue. 
Patients with a PSSS possibly indicating large artery occlusion may sometimes be best trans-
ferred directly to a comprehensive stroke center where endovascular recanalization interven-
tions may be available  [9] . The KPSS will thus allow adequate decision-making and transport 
in prehospital settings. Furthermore, pretreatment evaluation of stroke severity using the 
KPSS may predict long-term outcomes of stroke patients and has great potential as an im-
portant initial value for prehospital clinical research. Although we have no supporting data 
for this issue from previous studies, one proposal is that a certified assessment of pretreat-
ment stroke severity will be a future requirement for prehospital stroke clinical treatment 
trials investigating the development of adequate transportation systems.
    An important limitation of this study was the analysis of only a single dichotomized 
outcome using mRS. Then, substantial interrater variability of mRS measurement may be 
present because we are unable to conduct a structured assessment tool in order to reduce 
  Fig. 2.   A forest plot diagram showing factors for mRS 0–1 at 3 months after symptom onset in a multi-
variate logistic regression model. 34
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mRS variability. To confirm the utility of the KPSS in a Japanese prehospital setting, pro-
spective, multicenter trials should be extensively conducted.
    In conclusion, the KPSS shows promise as an excellent tool enabling paramedics to 
quantify stroke severity in the prehospital setting. Prehospital assessment of stroke severity 
using the KPSS may help to predict a favorable outcome in acute cerebral ischemia.
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